Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group

Patients with pancreatic ductal adenocarcinoma (PDAC) with peritoneal dissemination have a dismal prognosis because discontinuation of systemic chemotherapy is required for massive ascites or poor performance status. The natural history, diagnosis and treatment of PDAC with peritoneal dissemination...

Descripción completa

Detalles Bibliográficos
Autores principales: Satoi, Sohei, Takahara, Naminatsu, Fujii, Tsutomu, Isayama, Hiroyuki, Yamada, Suguru, Tsuji, Yasushi, Miyato, Hideyo, Yamaguchi, Hironori, Yamamoto, Tomohisa, Hashimoto, Daisuke, Yamaki, So, Nakai, Yousuke, Saito, Kei, Baba, Hayato, Watanabe, Toru, Ishii, Shigeto, Hayashi, Masamichi, Kurimoto, Keisuke, Shimada, Hideaki, Kitayama, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306579/
https://www.ncbi.nlm.nih.gov/pubmed/34855287
http://dx.doi.org/10.1002/jhbp.1085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306579/
https://www.ncbi.nlm.nih.gov/pubmed/34855287
http://dx.doi.org/10.1002/jhbp.1085

Ejemplares similares